Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

165.98
+1.490.91%
Post-market: 166.110.1300+0.08%19:53 EDT
Volume:3.18M
Turnover:527.99M
Market Cap:257.43B
PE:24.85
High:167.25
Open:164.04
Low:163.96
Close:164.49
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.84
T/O Rate:0.21%
Dividend:3.23
Dividend Rate:1.95%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.12
PE(LYR):25.38

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 24

Astrazeneca PLC Expected to Post Earnings of $2.54 a Share - Earnings Preview

Reuters
·
Jul 24

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Major Tech Stocks Sell-Off

MT Newswires Live
·
Jul 23

AstraZeneca announces Etcamah with CDK4/6 inhibitor approved in EU

TIPRANKS
·
Jul 23

Astrazeneca's Etcamah combination for ESR1-mutated advanced breast cancer

MT Newswires Live
·
Jul 23

European Union Grants Approval to AstraZeneca's New Breast Cancer Medication

Stock News
·
Jul 23

Astrazeneca PLC Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 23

What Bundibugyo Ebola Vaccines and Treatments are Under Development

Reuters
·
Jul 22

Royalty Pharma Acquires Royalty Interest in AstraZeneca's Cliramitug

MT Newswires Live
·
Jul 22

Jefferies Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Jul 22

AstraZeneca Halts Russian NMOSD Study: What It Means for AZN Investors

TIPRANKS
·
Jul 22

J.P. Morgan Sticks to Their Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Jul 21

Astrazeneca PLC Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 21

Market Chatter: AstraZeneca Unit Highlights Opportunities in Rare Diseases

MT Newswires Live
·
Jul 20

Earning Preview: AstraZeneca PLC this quarter’s revenue is expected to increase by 10.06%, and institutional views are bullish

Earnings Agent
·
Jul 20

AstraZeneca’s New Saruparib Trial Targets Next Wave of Prostate Cancer Growth

TIPRANKS
·
Jul 18

AstraZeneca’s ALICIA Real‑World CLL Study Wraps Up, Setting Up Fresh Data for AZN Investors

TIPRANKS
·
Jul 18

European Pharma Stocks' Underperformance Shouldn't Last

Dow Jones
·
Jul 17

Morgan Stanley Remains a Buy on AstraZeneca (AZN)

TIPRANKS
·
Jul 17

AstraZeneca price target lowered to 15,300 GBp at Morgan Stanley

TIPRANKS
·
Jul 17